Paragonix Technologies recently closed a $24 million Series B funding round. The Cambridge, Massachusetts-based company provides transplant centers and organ procurement organizations with medical devices designed for the preservation and transportation of donor organs.
Feeling good about the U.S. Supreme Court ruling on Myriad Genetics that prevents genes from being patented? You may want to rethink it. Although the decision may have paved the way for more open research, but in the long term it may also lead to some unintended consequences. Investors will shy away from primary research […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.